Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Change in Inventory (2019 - 2025)

Historic Change in Inventory for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $4654.0.

  • Bioadaptives' Change in Inventory changed N/A to $4654.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $25113.0, marking a year-over-year increase of 7810.64%. This contributed to the annual value of $6404.0 for FY2023, which is 5517.32% up from last year.
  • Latest data reveals that Bioadaptives reported Change in Inventory of $4654.0 as of Q3 2025.
  • Over the past 5 years, Bioadaptives' Change in Inventory peaked at $21469.0 during Q1 2025, and registered a low of -$13279.0 during Q4 2021.
  • In the last 5 years, Bioadaptives' Change in Inventory had a median value of $1744.0 in 2023 and averaged $1920.5.
  • Examining YoY changes over the last 5 years, Bioadaptives' Change in Inventory showed a top increase of 58268.16% in 2021 and a maximum decrease of 49579.73% in 2021.
  • Quarter analysis of 5 years shows Bioadaptives' Change in Inventory stood at -$13279.0 in 2021, then surged by 155.55% to $7377.0 in 2022, then grew by 8.87% to $8031.0 in 2023, then tumbled by 65.41% to $2778.0 in 2024, then skyrocketed by 67.53% to $4654.0 in 2025.
  • Its Change in Inventory stands at $4654.0 for Q3 2025, versus -$1010.0 for Q2 2025 and $21469.0 for Q1 2025.